Open Access

Co-existence of other copy number variations with 22q11.2 deletion or duplication: a modifier for variable phenotypes of the syndrome?

Molecular Cytogenetics20125:18

DOI: 10.1186/1755-8166-5-18

Received: 12 December 2011

Accepted: 9 April 2012

Published: 9 April 2012

Abstract

Background

The phenotype in patients with a 22q11.2 deletion or duplication can be extremely variable, and the causes of such as variations are not well known.

Results

We observed additional copy number variations (CNVs) in 2 of 15 cases with a 22q11.2 deletion or duplication. Both cases were newborn babies referred for severe congenital heart defects. The first case had a deletion with a size of approximately 1.56 Mb involving multiple genes including STS in the Xp22.31 region along with a 22q11.2 deletion. The second case had a duplication of 605 kb in the 15q13.3 region encompassing CHRNA7 and a deletion of 209 kb involving the RBFOX1 gene in the 16p13.2 region, in addition to 22q11.2 duplication.

Discussion

Our observations have shown that additional CNVs are not rare (2/15, 13%) in patients with a 22q11.2 deletion or duplication. We speculate that these CNVs may contribute to phenotype variations of 22q11.2 microdeletion/duplication syndromes as genomic modifiers.

Keywords

DiGeorge syndrome 22q11.2 microdeletion 22q11.2 microduplication Array CGH Copy number variations (CNVs)

Background

It is well known that the phenotype of patients with 22q11.2 microdeletion or microduplication can be extremely variable from near normal to severe developmental disabilities including congenital heart defects, learning disabilities, and risk of psychological problems such as attention-deficit hyperactivity disorder, autism-spectrum disorders and schizophrenia [1, 2]. The mechanisms that lead to extreme phenotype variations in this syndrome remain unknown. Prior to the clinical use of microarray based comparative genomic hybridization (array CGH), vast majority of patients with a 22q11.2 deletion or duplication were diagnosed by FISH [35], and therefore genomic changes other than the 22q11.2 region were barely known. Here, we report additional genomic aberrations detected by array CGH in two newborns, one had a deletion and the other had a duplication of the 22q11.2 region.

Case presentation

Patient 1

The patient was an infant girl, 15 days of age, born to a 23 year old healthy mother. The baby was delivered at the 38th week of gestation by C-section due to nuchal cord. The baby weighted 2.9 kg, with Apgar scores 8 at 1 min, 9 at 5 min, and 9 at 10 min. Management of the infant at delivery included stimulation and suction. Echocardiography showed tetralogy of Fallot with absent pulmonary valve and left hemitruncus. A computerized tomography (CT) scan of the thorax with contrast and 3D reconstruction showed a large right pulmonary artery compressing on both right and left main stem bronchi, but more significantly on the right bronchi during systole. The infant also had mild respiratory distress at birth, anemia, and feeding intolerance. She became increasingly tachypneic with chest X-ray findings of air trapping on the right lung, pulmonary edema on the left lung, and cardiomegaly. Abdominal ultrasound showed bilateral small kidneys. Other physical and ultrasound examinations were unremarkable, except for overriding toes.

Patient 2

Patient 2 was an infant boy, 15 days of age. He was delivered at 37th week of gestation to a 19-year-old mother by C-section due to IUGR. His birth weight was 2.25 kg with Apgar scores of 9, 9 and 9. No complications were reported in the mother during this pregnancy. The baby had normal tone and reflexes with apparently normal activities. He had micrognathia without other specific dysmorphic features. Systolic ejection murmur at the lower sternal border was noted. Ultrasound showed complex congenital heart defects including double outlet right ventricle with a large ventricular septal defect and pulmonary stenosis, mild right ventricular hypertrophy, mild tricuspid valve hypoplasia, pulmonary valve hypoplasia, and patent foramen ovale with bidirectional shunting. Other obvious abnormalities were not noted by physical examinations and routine laboratory tests. The maternal side of the family had a history of controlled hypertension and heart murmur without complications while the paternal side history was unremarkable.

Results

In patient 1, array CGH showed a 2.47 Mb deletion in the 22q11.2 region and a 1.56 Mb deletion in the Xp22.31 region (Figure 1A). In patient 2, array CGH detected multiple CNVs, including a 2.84 Mb duplication in the DiGeorge region, a 605 kb duplication in the 15q13.3 region and a 209 kb deletion in the 16p13.2 region (Figure 1B). Details of the CNVs in the two patients are summarized in Table 1. Conventional chromosome analysis revealed a normal karyotype in both patients. Parental studies were offered to the parents of both proband patients but were declined.
Figure 1

Complex pathogenic imbalances in two patients. A. A 2.47 Mb deletion at 22q11.21 and a 1.56 Mb deletion at Xp22.31 in patient 1. B. A 2.84 Mb duplication at 22q11.21, a 0.61 Mb duplication at 15q13.3, and a 0.21 Mb deletion at 16p13.2 in patient 2.

Table 1

CNVs involved in the two patients (hg18)

Patient

Imbalance

Size (MB)

ISCN description

Genes involved

1

del

2.47

22q11.21(17299942-19770514) × 1

More than 40 genes

including TBX1

 

del

1.56

Xp22.31(6498721-8057511) × 1

HDHD1A, STS, VCX, PNPLA4

2

dup

2.84

22q11.21(17299942-20139009) × 3

More than 40 genes

including TBX1

 

dup

0.605

15q13.3(29818304-30423251) × 3

CHRNA7

 

del

0.209

16p13.2(6776911-6986220) × 1

RBFOX1

Discussion

22q11.2 microdeletion and microduplication syndromes are mediated by nonallelic homologous recombination (NAHR) between region-specific low-copy repeats (LCRs) during meiosis [6]. The number of patients with a microduplication appears to be smaller than that of patients with a deletion although an equal frequency is expected [7, 8]. We have detected microdeletion or microduplication of the 22q11.2 DiGeorge region in 15 of 1292 cases (1.16%) referred for intellectual disabilities and/or congenital anomalies in the past several years. Among them, ten patients had a 2.4 Mb ~ 2.9 Mb deletion; two patients had a duplication of the same region; one had a 1.4 Mb deletion and two had a 500-600 Kb duplication.

A DNA segment with a size of approximately 3 Mb that encompasses over 40 functional genes is involved in about 90% of 22q11.2 microdeletions or microduplications [2]. Clinical features of congenital heart defects in 22q11.2 deletion syndromes are usually associated with the common 3 Mb deletions involving TBX1, while atypical deletions may show variable phenotypes modified by deletion location, size and other factors [9, 10]. However, extremely variable phenotypes have been reported in patients with the same 22q11.2 deletion, and the mechanisms leading to such variations remain unknown [11].

We detected complex CNVs in 2 of the 15 cases (13%), suggesting that additional CNVs are not rare among the patients with a 22q11.2 microdeletion or microduplication. Our patient 1 had an Xp22.31 deletion involving HDHD1A, STS, VCX, PNPLA4 genes in addition to the typical 22q11.2 deletion. STS deletion is associated with X-linked ichthyosis (XLI) in male due to deficiency of steroid sulfatase (STS) activity [12]. We speculate that the genes involved in Xp22.3 and 22q11.2 deletions may interact in normal development given the large number of genes involved.

Our patient 2 had a duplication of the CHRNA7 gene on chromosome 15q and a partial deletion of the RBFOX1 gene on chromosome 16p in addition to the 22q11.2 duplication. The microduplication phenotypes can be very different even within the same family with the exactly same duplication [6]. While the majority of patients with a 22q11.2 deletion have congenital heart defects, most of the cases with duplication of this region do not have [6]. Our patient 2 had severe congenital heart defect. It is not known if the additional CNVs have contributed to the severe abnormal heart development in this patient, but this possibility cannot be excluded. It is well known that neuropsychiatric disorders such as schizophrenia, attention deficit disorder, depression and autism frequently occur in the individuals with a 22q11.2 deletion or duplication [1315]. Copy number variations of CHRNA7 and RBFOX1 have been reported in patients with mental retardation, autism and schizophrenia or seizure [1618]. It is likely that CNVs of CHRNA7 and RBFOX1 would add additional risk for psychological diseases in the patient when he grows up.

Conclusions

In summary, the observation of additional CNVs in our two cases with 22q11.2 microdeletion/duplication suggests that complex genomic changes are not rare in DiGeorge patients and they may, as genomic modifiers, contribute to the variable phenotypes of the disease. Continuing follow-up with these two patients and accumulation of more cases similar to ours in literature may help our understanding on the complicated phenotypes of the 22q11.2 microdeletion/duplication syndrome.

Materials and methods

Chromosome analysis

Conventional GTG banded chromosome analysis was performed at the level of resolution of 500-550 bands per hypoid and reported according to ISCN 2009.

Array CGH

Array CGH was performed as described [19]. Briefly, DNA was extracted from patient peripheral blood using commercially available DNA isolation kits (Qiagen Sciences, Maryland) according to the manufacturer's instructions. A customized genome-wide oligonucleotide array (Agilent Technologies, Santa Clara, CA) was used for the studies. This platform was composed of 44,290 60-mer oligonucleotide probes with an average spacing of 30-35 kb genome-wide. Probes are enriched for the regions and genes known to be associated with syndromes or developmental disorders. Patient and reference DNA samples were differentially labeled and cohybridized to the arrays. Hybridized slides were scanned with microarray scanner (Agilent G2505B), and analyzed with Feature Extraction and DNA Analytics 4.0 (Agilent Technologies). The assembly hg18/build36 of the human genome was used for the two cases.

Consent

All patients under the care of Jackson Memorial Hospital (JMH) signed a written informed consent that allows the medical staff of JMH and University of Miami School of Medicine to use their medical records for medical research and education purpose without revealing patient identification. A copy of the written consent is available to review by the Editor-in-Chief of this journal.

Abbreviations

FISH: 

fluorescence in situ hybridization

CNVs: 

Copy number variations

ISCN: 

International system for human cytogenetic nomenclature

CT: 

Computerized tomography

IUGR: 

Intrauterine growth restriction

CGH: 

Comparative genomic hybridization

NAHR: 

Nonallelic homologous recombination

LCRs: 

Low-copy repeats

XLI: 

X-linked ichthyosis

Declarations

Authors’ Affiliations

(1)
Department of Pathology, University of Miami Miller School of Medicine
(2)
Dr. John T. Macdonald Department of Human Genetics, University of Miami Miller School of Medicine
(3)
John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine
(4)
Jackson Memorial Hospital, University of Miami Miller School of Medicine

References

  1. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, Moss E, Solot C, Wang P, Jacobs I, Handler S, Knightly C, Heher K, Wilson M, Ming JE, Grace K, Driscoll D, Pasquariello P, Randall P, Larossa D, Emanuel BS, Zackai EH: The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999, 10: 11–24.PubMedGoogle Scholar
  2. Swillen A, Vogels A, Devriendt K, Fryns JP: Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 2000, 97: 128–135. 10.1002/1096-8628(200022)97:2<128::AID-AJMG4>3.0.CO;2-ZView ArticlePubMedGoogle Scholar
  3. Emanuel BS, Budarf ML, Sellinger B, Goldmuntz E, Driscoll DA: Detection of microdeletions of 22q11.2 with fluorescence in situ hybridization (FISH): diagnosis of DiGeorge syndrome (DGS), velo-cardio facial (VCF) syndrome, CHARGE association and conotruncal cardiac malformations. Am J Hum Genet 1992, 51(Suppl):A3.Google Scholar
  4. Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, Dawson DB, Thorland EC, Lorentz CP, Goldstein JL, McDonald MT, Smith WE, Simon-Fayard E, Alexander AA, Kulharya AS, Ketterling RP, Clark RD, Jalal SM: Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 2003, 73: 1027–1040. 10.1086/378818PubMed CentralView ArticlePubMedGoogle Scholar
  5. Cotter PD, Nguyen H, Tung G, Rauen KA: Incidence of microduplication 22q11.2 in patients referred for FISH testing for velo cardiofacial and DiGeorge syndromes. Eur J Hum Genet 2005, 13: 1245–1246. 10.1038/sj.ejhg.5201494View ArticlePubMedGoogle Scholar
  6. Gothelf D, Frisch A, Michaelovsky E, Weizman A, Shprintzen RJ: Velo-cardio-facial syndrome. J Ment Health Res Intellect Disabil 2009, 2: 149–167. 10.1080/19315860902756136PubMed CentralView ArticlePubMedGoogle Scholar
  7. De La Rochebrochard C, Joly-Hélas G, Goldenberg A, Durand I, Laquerrière A, Ickowicz V, Saugier-Veber P, Eurin D, Moirot H, Diguet A, de Kergal F, Tiercin C, Mace B, Marpeau L, Frebourg T: The intrafamilial variability of the 22q11.2 microduplication encompasses a spectrum from minor cognitive deficits to severe congenital anomalies. Am J Med Genet A 2006, 140: 1608–1613.View ArticlePubMedGoogle Scholar
  8. Ou Z, Berg JS, Yonath H, Enciso VB, Miller DT, Picker J, Lenzi T, Keegan CE, Sutton VR, Belmont J, Chinault AC, Lupski JR, Cheung SW, Roeder E, Patel A: Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet Med 2008, 10: 267–277. 10.1097/GIM.0b013e31816b64c2View ArticlePubMedGoogle Scholar
  9. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R: Role of TBX1 in human del22q11.2 syndrome. Am J Med Genet 1999, 86: 27–33. 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7View ArticleGoogle Scholar
  10. Rauch A, Zink S, Zweier C, Thiel CT, Koch A, Rauch R, Lascorz J, Hüffmeier U, Weyand M, Singer H, Hofbeck M: Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet 2005, 42: 871–876. 10.1136/jmg.2004.030619PubMed CentralView ArticlePubMedGoogle Scholar
  11. Garcia-Miñaur S, Fantes J, Murray RS, Porteous ME, Strain L, Burns JE, Stephen J, Warner JP: A novel atypical 22q11.2 distal deletion in father and son. J Med Genet 2002, 39: E62. 10.1136/jmg.39.10.e62PubMed CentralView ArticlePubMedGoogle Scholar
  12. Kent L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR, McMahon R, Yates JR: X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet 2008, 45: 519–524. 10.1136/jmg.2008.057729View ArticlePubMedGoogle Scholar
  13. Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S: Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 2009, 48: 1060–1068. 10.1097/CHI.0b013e3181b76683View ArticlePubMedGoogle Scholar
  14. Lo-Castro A, Galasso C, Cerminara C, El-Malhany N, Benedetti S, Nardone AM, Curatolo P: Association of syndromic mental retardation and autism with 22q11.2 duplication. Neuropediatrics 2009, 40: 137–140. 10.1055/s-0029-1237724View ArticlePubMedGoogle Scholar
  15. Portnoï MF: Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet 2009, 52: 88–93. 10.1016/j.ejmg.2009.02.008View ArticlePubMedGoogle Scholar
  16. Szafranski P, Schaaf CP, Person RE, Gibson IB, Xia Z, Mahadevan S, Wiszniewska J, Bacino CA, Lalani S, Potocki L, Kang SH, Patel A, Cheung SW, Probst FJ, Graham BH, Shinawi M, Beaudet AL, Stankiewicz P: Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010, 31: 840–850. 10.1002/humu.21284PubMed CentralView ArticlePubMedGoogle Scholar
  17. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, Cook E, Geschwind DH: Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B 2007, 144B: 869–876. 10.1002/ajmg.b.30530View ArticleGoogle Scholar
  18. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH: Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474: 380–384. 10.1038/nature10110PubMed CentralView ArticlePubMedGoogle Scholar
  19. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, Morales A, Carver V, Benke P, Mundy P, Elsas LJ: Detection of pathogenic gene copy number variations in patients with mental retardationby genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat 2007, 28: 1124–1132. 10.1002/humu.20581View ArticlePubMedGoogle Scholar

Copyright

© Li et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.